/
Mol Ther
Targeting CD33 in chemoresistant AML patient-derived xenografts by CAR-CIK cells modified with an improved SB transposon system
- M.C. Rotiroti
- C. Buracchi
- S. Arcangeli
- S. Galimberti
- M.G. Valsecchi
- V.M. Perriello
- T. Rasko
- G. Alberti
- C.F. Magnani
- C. Cappuzzello
- F. Lundberg
- A. Pande
- G. Dastoli
- M. Introna
- M. Serafini
- E. Biagi
- Z. Izsvák
- A. Biondi
- S. Tettamanti